• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Solvay

Anonymous board for Solvay
Replies
53
Views
29K
anonymous
Replies
0
Views
3K
anonymous
Replies
1
Views
5K
anonymous
Replies
24
Views
16K
Anonymous
Replies
6
Views
6K
Anonymous
Replies
143
Views
67K
Anonymous
Replies
30
Views
18K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
3
Views
6K
Anonymous
Replies
28
Views
17K
Anonymous
Replies
44
Views
37K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
4
Views
3K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
12
Views
7K
Anonymous
Replies
0
Views
6K
Anonymous